At a Washington International Trade Association event last week on "Trade and National Security: China and Outbound Investment in the Crosshairs," Clete Willems, the Deputy Assistant to the President for International Economics and Deputy NEC Director during the Trump administration, provided a useful overview of the current discussion

U.S. medical device giant Boston Scientific announced this week that it is building its first China factory in Shanghai, as a local government official promised "a first-class commercial environment that is market-oriented, governed by law, and internationalized."

At an event held by the Council on Foreign Relations (CFR) yesterday, the two leaders of the House Select Committee on Strategic Competition Between the United States and the Chinese Communist Party, Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL), spoke with CFR President Mike Froman about issues

This statement came after China signed the first FTA that contains negative lists for services trade and investment.

Last month, the Beijing government issued a ruling that imposes a US$1.5 million penalty on due-diligence firm Mintz, and provided some details on the legal reasoning behind the investigation that shocked many western businesses and observers.

During this week's trip to China, U.S. Commerce Secretary Gina Raimondo discussed export controls, China's business environment and U.S.-China trade relations at meetings with Chinese officials and made additional statements in media interviews. Here are some highlights of her statements.

At yesterday's press conference, the spokesperson for China's Ministry of Commerce (MOFCOM) commented on the recent U.S. executive order that restricts outbound investment in China, and provided updates on the ongoing trade barrier investigation against Taiwan and China's export controls on gallium and